| 1 | 1 | | I |
|---|
| 2 | 2 | | 119THCONGRESS |
|---|
| 3 | 3 | | 1 |
|---|
| 4 | 4 | | STSESSION H. R. 1561 |
|---|
| 5 | 5 | | To require research with respect to fentanyl and xylazine test strips, to |
|---|
| 6 | 6 | | authorize the use of grant funds for such test strips, and for other purposes. |
|---|
| 7 | 7 | | IN THE HOUSE OF REPRESENTATIVES |
|---|
| 8 | 8 | | FEBRUARY25, 2025 |
|---|
| 9 | 9 | | Ms. C |
|---|
| 10 | 10 | | ROCKETT(for herself and Mr. GOODEN) introduced the following bill; |
|---|
| 11 | 11 | | which was referred to the Committee on Energy and Commerce |
|---|
| 12 | 12 | | A BILL |
|---|
| 13 | 13 | | To require research with respect to fentanyl and xylazine |
|---|
| 14 | 14 | | test strips, to authorize the use of grant funds for such |
|---|
| 15 | 15 | | test strips, and for other purposes. |
|---|
| 16 | 16 | | Be it enacted by the Senate and House of Representa-1 |
|---|
| 17 | 17 | | tives of the United States of America in Congress assembled, 2 |
|---|
| 18 | 18 | | SECTION 1. SHORT TITLE. 3 |
|---|
| 19 | 19 | | This Act may be cited as the ‘‘Advancing Lifesaving 4 |
|---|
| 20 | 20 | | Efforts with Rapid Test strips for Communities Act’’ or 5 |
|---|
| 21 | 21 | | the ‘‘ALERT Communities Act’’. 6 |
|---|
| 22 | 22 | | SEC. 2. FIRST RESPONDER TRAINING. 7 |
|---|
| 23 | 23 | | Section 546(c) of the Public Health Service Act (42 8 |
|---|
| 24 | 24 | | U.S.C. 290ee–1(c)) is amended— 9 |
|---|
| 25 | 25 | | VerDate Sep 11 2014 00:50 Mar 13, 2025 Jkt 059200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H1561.IH H1561 |
|---|
| 26 | 26 | | ssavage on LAPJG3WLY3PROD with BILLS 2 |
|---|
| 27 | 27 | | •HR 1561 IH |
|---|
| 28 | 28 | | (1) in paragraph (3), by striking ‘‘; and’’ and 1 |
|---|
| 29 | 29 | | inserting a semicolon; 2 |
|---|
| 30 | 30 | | (2) in paragraph (4), by striking the period and 3 |
|---|
| 31 | 31 | | inserting ‘‘; and’’; and 4 |
|---|
| 32 | 32 | | (3) by adding at the end the following: 5 |
|---|
| 33 | 33 | | ‘‘(5) train and provide resources for first re-6 |
|---|
| 34 | 34 | | sponders and members of other relevant community 7 |
|---|
| 35 | 35 | | sectors on carrying and facilitating access to 8 |
|---|
| 36 | 36 | | fentanyl or xylazine test strips (as defined in section 9 |
|---|
| 37 | 37 | | 5 of the Advancing Lifesaving Efforts with Rapid 10 |
|---|
| 38 | 38 | | Test strips for Communities Act).’’. 11 |
|---|
| 39 | 39 | | SEC. 3. RESEARCH AND MARKETING FRAMEWORKS FOR 12 |
|---|
| 40 | 40 | | TEST STRIP TECHNOLOGY. 13 |
|---|
| 41 | 41 | | The Secretary of Health and Human Services, in con-14 |
|---|
| 42 | 42 | | sultation with the Director of the National Institutes of 15 |
|---|
| 43 | 43 | | Health, the Director of the Office of National Drug Con-16 |
|---|
| 44 | 44 | | trol Policy, the Commissioner of Food and Drugs, and the 17 |
|---|
| 45 | 45 | | Administrator of the Drug Enforcement Administration, 18 |
|---|
| 46 | 46 | | shall develop and make publicly available research and 19 |
|---|
| 47 | 47 | | marketing frameworks for developing, improving, and 20 |
|---|
| 48 | 48 | | evaluating test strip technology for detecting fentanyl and 21 |
|---|
| 49 | 49 | | other dangerous substances. Such frameworks shall— 22 |
|---|
| 50 | 50 | | (1) include standards and guidance for manu-23 |
|---|
| 51 | 51 | | facturers seeking to develop and test new test strip 24 |
|---|
| 52 | 52 | | technology; 25 |
|---|
| 53 | 53 | | VerDate Sep 11 2014 00:50 Mar 13, 2025 Jkt 059200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H1561.IH H1561 |
|---|
| 54 | 54 | | ssavage on LAPJG3WLY3PROD with BILLS 3 |
|---|
| 55 | 55 | | •HR 1561 IH |
|---|
| 56 | 56 | | (2) emphasize bringing new test strip tech-1 |
|---|
| 57 | 57 | | nology intended for testing human specimens in clin-2 |
|---|
| 58 | 58 | | ical settings to support on-site clinical decision-mak-3 |
|---|
| 59 | 59 | | ing; and 4 |
|---|
| 60 | 60 | | (3) include guidance on available authorization 5 |
|---|
| 61 | 61 | | pathways for test strips described in paragraphs (1) 6 |
|---|
| 62 | 62 | | and (2). 7 |
|---|
| 63 | 63 | | SEC. 4. STUDY ON FENTANYL TEST STRIP INTERVENTIONS. 8 |
|---|
| 64 | 64 | | The Secretary of Health and Human Services shall— 9 |
|---|
| 65 | 65 | | (1) conduct a study on the impact of the avail-10 |
|---|
| 66 | 66 | | ability, accessibility, and usage of drug checking 11 |
|---|
| 67 | 67 | | supplies, including test strips, on frequency of over-12 |
|---|
| 68 | 68 | | dose, overdose deaths, and engagement in substance 13 |
|---|
| 69 | 69 | | use disorder treatment; and 14 |
|---|
| 70 | 70 | | (2) not later than 2 years after the date of en-15 |
|---|
| 71 | 71 | | actment of this Act, submit to Congress a report on 16 |
|---|
| 72 | 72 | | the study conducted under paragraph (1). 17 |
|---|
| 73 | 73 | | SEC. 5. DEFINITION. 18 |
|---|
| 74 | 74 | | In this Act, the term ‘‘test strip’’ means a rapid re-19 |
|---|
| 75 | 75 | | sponse, single use diagnostic that can be used to detect 20 |
|---|
| 76 | 76 | | the adulteration of a drug with, or the presence in a 21 |
|---|
| 77 | 77 | | human specimen of, any substance that may lead to in-22 |
|---|
| 78 | 78 | | creased morbidity or mortality, such as fentanyl, xylazine, 23 |
|---|
| 79 | 79 | | or another synthetic opioid or emerging substance. 24 |
|---|
| 80 | 80 | | Æ |
|---|
| 81 | 81 | | VerDate Sep 11 2014 00:50 Mar 13, 2025 Jkt 059200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6301 E:\BILLS\H1561.IH H1561 |
|---|
| 82 | 82 | | ssavage on LAPJG3WLY3PROD with BILLS |
|---|